|
1
|
Bray F, Laversanne M, Sung H, Ferlay J,
Siegel RL, Soerjomataram I and Jemal A: Global cancer statistics
2022: GLOBOCAN estimates of incidence and mortality worldwide for
36 cancers in 185 countries. CA Cancer J Clin. Apr 4–2024.(Epub
ahead of print). View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zheng YZ, Hu X and Shao ZM:
Clinicopathological characteristics and survival outcomes in
invasive papillary carcinoma of the breast: A SEER population-based
study. Sci Rep. 6:240372016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Pal SK, Lau SK, Kruper L, Nwoye U,
Garberoglio C, Gupta RK, Paz B, Vora L, Guzman E, Artinyan A and
Somlo G: Papillary carcinoma of the breast: An overview. Breast
Cancer Res Treat. 122:637–645. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tay TKY and Tan PH: Papillary neoplasms of
the breast-reviewing the spectrum. Mod Pathol. 34:1044–1061. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Louwman MWJ, Vriezen M, van Beek MWPM,
Nolthenius-Puylaert MCBJET, van der Sangen MJC, Roumen RM, Kiemeney
LALM and Coebergh JWW: Uncommon breast tumors in perspective:
Incidence, treatment and survival in the Netherlands. Int J Cancer.
121:127–135. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Soe AM, Joseph G, Guevara E and Xiao P:
Primary neuroendocrine carcinoma of the breast metastatic to the
bones, which chemotherapy? Breast J. 23:589–593. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Blaumeiser B, Tjalma WA, Verslegers I, De
Schepper AM and Buytaert P: Invasive papillary carcinoma of the
male breast. Eur Radiol. 12:2207–2210. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sinn HP and Kreipe H: A brief overview of
the WHO classification of breast tumors, 4th edition, focusing on
issues and updates from the 3rd edition. Breast Care (Basel).
8:149–154. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tan PH, Ellis I, Allison K, Brogi E, Fox
SB, Lakhani S, Lazar AJ, Morris EA, Sahin A, Salgado R, et al: The
2019 World Health Organization classification of tumours of the
breast. Histopathology. 77:181–185. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Gogoi G, Dowerah S, Kashyap AS and
Terangpi M: Papillary carcinoma of breast: An institutional
overview of a rare histopathologic type. J Cancer Res Ther.
19:511–515. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Pant I and Joshi SC: Invasive papillary
carcinoma of the male breast: Report of a rare case and review of
the literature. J Cancer Res Ther. 5:216–218. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vani D, Geetanjali S, Punja GM and
Bharathi M: A case of invasive papillary breast carcinoma: Fierce
façade with favorable prognosis. J Cancer Res Ther. 11:10292015.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bajaj JS, O'Leary JG, Lai JC, Wong F, Long
MD, Wong RJ and Kamath PS: Acute-on-chronic liver failure clinical
guidelines. Am J Gastroenterol. 117:225–252. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Spak DA, Plaxco JS, Santiago L, Dryden MJ
and Dogan BE: BI-RADS® fifth edition: A summary of
changes. Diagn Interv Imaging. 98:179–190. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Rehman B, Mumtaz A, Sajjad B, Urooj N,
Khan SM, Zahid MT, Mannan H, Chaudhary MZ, Khan A and Parvaiz MA:
Papillary carcinoma of breast: Clinicopathological characteristics,
management, and survival. Int J Breast Cancer. 2022:54278372022.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Kulka J, Madaras L, Floris G and Lax SF:
Papillary lesions of the breast. Virchows Arch. 480:65–84. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Morgan S, Dodington D, Wu JM and
Turashvili G: Solid papillary carcinoma and encapsulated papillary
carcinoma of the breast: Clinical-pathologic features and basement
membrane studies of 50 cases. Pathobiology. 88:359–373. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bai J and Wang G: Encapsulated papillary
carcinoma of the breast. Radiology. 308:e2310382023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hartrampf CR, Scheflan M and Black PW:
Breast reconstruction with a transverse abdominal island flap.
Plast Reconstr Surg. 69:216–225. 1982. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ter Louw RP and Nahabedian MY: Prepectoral
breast reconstruction. Plast Reconstr Surg. 140:51S–59S. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rakha EA, El-Sayed ME, Lee AHS, Elston CW,
Grainge MJ, Hodi Z, Blamey RW and Ellis IO: Prognostic significance
of Nottingham histologic grade in invasive breast carcinoma. J Clin
Oncol. 26:3153–3158. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Gnant M, Fitzal F, Rinnerthaler G, Steger
GG, Greil-Ressler S, Balic M, Heck D, Jakesz R, Thaler J, Egle D,
et al: Duration of adjuvant aromatase-inhibitor therapy in
postmenopausal breast cancer. N Engl J Med. 385:395–405. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wolff AC, Somerfield MR, Dowsett M,
Hammond MEH, Hayes DF, McShane LM, Saphner TJ, Spears PA and
Allison KH: Human epidermal growth factor receptor 2 testing in
breast cancer: ASCO-college of american pathologists guideline
update. J Clin Oncol. 41:3867–3872. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Elghobashy M, Jenkins S, Shulman Z, O'Neil
A, Kouneli S and Shaaban AM: Tall cell carcinoma with reversed
polarity: Case report of a rare special type of breast cancer and
review of the literature. Biomedicines. 11:23762023. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Rakha EA and Ellis IO: Diagnostic
challenges in papillary lesions of the breast. Pathology.
50:100–110. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Eiada R, Chong J, Kulkarni S, Goldberg F
and Muradali D: Papillary lesions of the breast: MRI, ultrasound,
and mammographic appearances. AJR Am J Roentgenol. 198:264–271.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Dugandzija T, Sekerija M, Hinic N,
Rajcevic S and Kusturica MP: Trend analyses of breast cancer
incidence and mortality in Vojvodina. J BUON. 25:655–661.
2020.PubMed/NCBI
|
|
28
|
Anderson WF, Chu KC, Chang S and Sherman
ME: Comparison of age-specific incidence rate patterns for
different histopathologic types of breast carcinoma. Cancer
Epidemiol Biomarkers Prev. 13:1128–1135. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu ZY, Liu N, Wang YH, Yang CC, Zhang J,
Lv SH and Niu Y: Clinicopathologic characteristics and molecular
subtypes of invasive papillary carcinoma of the breast: A large
case study. J Cancer Res Clin Oncol. 139:77–84. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Huang K, Appiah L, Mishra A, Bagaria SP,
Gabriel ME and Misra S: Clinicopathologic characteristics and
prognosis of invasive papillary carcinoma of the breast. J Surg
Res. 261:105–112. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Chen S, Wang J, Yang L, Ji M and Chen S:
Comparative analysis of clinicopathologic characteristics and
molecular subtypes of invasive papillary carcinoma of the breast
and invasive ductal carcinoma: Results from SEER database. J BUON.
26:1991–2002. 2021.PubMed/NCBI
|
|
32
|
Catanzariti F, Avendano D, Cicero G,
Garza-Montemayor M, Sofia C, Venanzi Rullo E, Ascenti G,
Pinker-Domenig K and Marino MA: High-risk lesions of the breast:
Concurrent diagnostic tools and management recommendations.
Insights Imaging. 12:632021. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Mitnick JS, Vazquez MF, Harris MN,
Schechter S and Roses DF: Invasive papillary carcinoma of the
breast: Mammographic appearance. Radiology. 177:803–806. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vdovenko AA: Pathology of breast papillary
neoplasms: Community hospital experience. Ann Diagn Pathol.
49:1516052020. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Ghannam SF, Rutland CS, Allegrucci C,
Mongan NP and Rakha E: Encapsulated papillary carcinoma of the
breast: Does it have a native basement membrane? Histopathology.
83:376–393. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Rakha EA, Gandhi N, Climent F, van Deurzen
CHM, Haider SA, Dunk L, Lee AHS, Macmillan D and Ellis IO:
Encapsulated papillary carcinoma of the breast: An invasive tumor
with excellent prognosis. Am J Surg Pathol. 35:1093–1103. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Zhao H and Lou S: Clinicopathological
characteristics and treatment of solid papillary carcinoma of the
breast. Asian J Surg. 46:3389–3390. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Otsuki Y, Suwa K, Ohtsuka S, Mori N,
Yoshida M, Serizawa A, Shimizu SI and Kobayashi H: A large-scale
clinicopathological and long-term follow-up study of solid
papillary carcinoma of the breast. Virchows Arch. 482:687–695.
2023. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Saremian J and Rosa M: Solid papillary
carcinoma of the breast: A pathologically and clinically distinct
breast tumor. Arch Pathol Lab Med. 136:1308–1311. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Zhang X, Huang B, Wu K and Fu S:
Infiltrative solid papillary carcinoma of the breast with axillary
lymph node metastasis: A case report. BMC Womens Health.
23:4532023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Duprez R, Wilkerson PM, Lacroix-Triki M,
Lambros MB, MacKay A, A'Hern R, Gauthier A, Pawar V, Colombo PE,
Daley F, et al: Immunophenotypic and genomic characterization of
papillary carcinomas of the breast. J Pathol. 226:427–441. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Fisher ER, Palekar AS, Redmond C, Barton B
and Fisher B: Pathologic findings from the national surgical
adjuvant breast project (protocol no. 4). VI. Invasive papillary
cancer. Am J Clin Pathol. 73:313–322. 1980. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Coca-Pelaz A, Shah JP, Hernandez-Prera JC,
Ghossein RA, Rodrigo JP, Hartl DM, Olsen KD, Shaha AR, Zafereo M,
Suarez C, et al: Papillary thyroid cancer-aggressive variants and
impact on management: A narrative review. Adv Ther. 37:3112–3128.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kim HJ, Kim JK and Cho KS: CT features of
serous surface papillary carcinoma of the ovary. AJR Am J
Roentgenol. 183:1721–1724. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Silver SA and Askin FB: True papillary
carcinoma of the lung: A distinct clinicopathologic entity. Am J
Surg Pathol. 21:43–51. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ye F, Yu P, Li N, Yang A, Xie X, Tang H
and Liu P: Prognosis of invasive micropapillary carcinoma compared
with invasive ductal carcinoma in breast: A meta-analysis of PSM
studies. Breast. 51:11–20. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yang YL, Liu BB, Zhang X and Fu L:
Invasive micropapillary carcinoma of the breast: An update. Arch
Pathol Lab Med. 140:799–805. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Liu C, Zhou J, Chang C and Zhi W:
Feasibility of shear wave elastography imaging for evaluating the
biological behavior of breast cancer. Front Oncol. 11:8201022021.
View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Peck DR: Biologic behavior of breast
cancers. JAMA. 241:27841979. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Suh YJ, Shin H and Kwon TJ: Natural
history of invasive papillary breast carcinoma followed for 10
years: A case report and literature review. Case Rep Med.
2017:37253912017. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Rakha EA, Ahmed MA and Ellis IO: Papillary
carcinoma of the breast: diagnostic agreement and management
implications. Histopathology. 69:862–870. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Hashmi AA, Munawar S, Rehman N, Ahmed O,
Islam S, Asghar IA, Afzal A, Irfan M, Shamail F and Ali SJ:
Invasive papillary carcinoma of the breast: Clinicopathological
features and hormone receptor profile. Cureus.
13:e134802021.PubMed/NCBI
|
|
53
|
Terzi A and Uner AH: An unusual case of
invasive papillary carcinoma of the breast. Indian J Pathol
Microbiol. 55:543–545. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Piscuoglio S, Ng CKY, Martelotto LG,
Eberle CA, Cowell CF, Natrajan R, Bidard FC, De Mattos-Arruda L,
Wilkerson PM, Mariani O, et al: Integrative genomic and
transcriptomic characterization of papillary carcinomas of the
breast. Mol Oncol. 8:1588–1602. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Di Cosimo S and Baselga J:
Phosphoinositide 3-kinase mutations in breast cancer: A ‘good’
activating mutation? Clin Cancer Res. 15:5017–5019. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Natrajan R, Lambros MB, Rodríguez-Pinilla
SM, Moreno-Bueno G, Tan DSP, Marchió C, Vatcheva R, Rayter S,
Mahler-Araujo B, Fulford LG, et al: Tiling path genomic profiling
of grade 3 invasive ductal breast cancers. Clin Cancer Res.
15:2711–2722. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Jenkins S, Kachur ME, Rechache K, Wells JM
and Lipkowitz S: Rare breast cancer subtypes. Curr Oncol Rep.
23:542021. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Li X, Huang R, Ma L, Liu S and Zong X:
Locoregional surgical treatment improves the prognosis in primary
metastatic breast cancer patients with a single distant metastasis
except for brain metastasis. Breast. 45:104–112. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Lee CM, Zheng H, Tan VKM, Tan TJY,
Kanesvaran R, Wong FY, Sim YR, Yong WS, Madhukumar P, Ong KW and
Tan BKT: Surgery for early breast cancer in the extremely elderly
leads to improved outcomes-an Asian population study. Breast.
36:44–48. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Arora R, Gupta R, Sharma A and Dinda AK:
Invasive papillary carcinoma of male breast. Indian J Pathol
Microbiol. 53:135–137. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Hong R and Xu B: Breast cancer: An
up-to-date review and future perspectives. Cancer Commun (Lond).
42:913–936. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Waks AG and Winer EP: Breast cancer
treatment: A review. JAMA. 321:288–300. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Fakhreddine MH, Haque W, Ahmed A, Schwartz
MR, Farach AM, Paulino AC, Bonefas E, Miltenburg D, Niravath P,
Butler EB and Teh BS: Prognostic factors, treatment, and outcomes
in early stage, invasive papillary breast cancer: A SEER
investigation of less aggressive treatment in a favorable
histology. Am J Clin Oncol. 41:532–537. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Lewis L, Thompson B, Stellmaker R and
Koelmeyer L: Body composition and chemotherapy toxicities in breast
cancer: A systematic review of the literature. J Cancer Surviv. Jan
11–2024.(Epub ahead of print). View Article : Google Scholar
|
|
65
|
Licaj I, Coquan E, Dabakuyo-Yonli TS,
Dauchy S, Vaz Luis I, Charles C, Lemogne C, Tredan O, Vanlemmens L,
Jouannaud C, et al: Baseline quality of life and chemotherapy
toxicities in patients with early breast cancer. Cancer.
129:1085–1095. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Battisti NML, Joshi K, Nasser MS and Ring
A: Systemic therapy for older patients with early breast cancer.
Cancer Treat Rev. 100:1022922021. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Zhang S, Liu Y, Liu X, Liu Y and Zhang J:
Prognoses of patients with hormone receptor-positive and human
epidermal growth factor receptor 2-negative breast cancer receiving
neoadjuvant chemotherapy before surgery: A retrospective analysis.
Cancers (Basel). 15:11572023. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Coates AS, Colleoni M and Goldhirsch A: Is
adjuvant chemotherapy useful for women with luminal a breast
cancer? J Clin Oncol. 30:1260–1263. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Goel S, Bergholz JS and Zhao JJ: Targeting
CDK4 and CDK6 in cancer. Nat Rev Cancer. 22:356–372. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Saita C, Goto R, Aruga T, Idera N, Honda
Y, Horiguchi K, Miyamoto H, Horiguchi S, Yamashita T and Kuroi K:
Invasive papillary carcinoma treated with neoadjuvant endocrine
therapy in which pathological complete response was achieved. BMC
Res Notes. 9:462016. View Article : Google Scholar : PubMed/NCBI
|
|
71
|
De Placido S, Gallo C, De Laurentiis M,
Bisagni G, Arpino G, Sarobba MG, Riccardi F, Russo A, Del Mastro L,
Cogoni AA, et al: Adjuvant anastrozole versus exemestane versus
letrozole, upfront or after 2 years of tamoxifen, in
endocrine-sensitive breast cancer (FATA-GIM3): A randomised, phase
3 trial. Lancet Oncol. 19:474–485. 2018. View Article : Google Scholar : PubMed/NCBI
|
